AMITA Event May 10, 2011: Hepregen CEO Bonnie Fendrock on Technology Commercialization

May 3, 2011

If you’d like to learn more about technology commercialization, next week the Association of MIT Alumnae (AMITA) has organized an outstanding panel of entrepreneurs, investors, and IP experts. Of particular interest to FluidicMEMS readers, Hepregen CEO Bernadette (Bonnie) Fendrock is included on the panel. Hepregen is developing a bioengineered microliver platformfor advanced toxicity screening and drug discovery. Around 2008 the startup was spun out ofSangeeta Bhatia’s lab, which has been mentioned before on this blog for their pioneering workin microfluidics, BioMEMS, and nanotechnology for biological and biomedical applications. Check it out!

 

From the AMITA announcement:

 

Keys to Successful Technology Commercialization
May 10, 2011, MIT Stata Center Rm 141
6:30-7:00 PM Networking reception sponsored by Goodwin Procter || 7:00-9:00 Panel discussion with Q&A

 

Our panelists will discuss their experiences with technology commercialization and entrepreneurship. They will draw from their expertise in high tech and biotech to point out important marketing and technical challenges involved with bringing technologies to market. Speakers will also discuss how their education and industry experience have impacted their perspectives and career paths.

 

Our distinguished panelists include –
Bernadette Fendrock, XXV SM ‘82, MBA, Co-founder, President & CEO, Hepregen 
Marina Hatsopoulos, II SM ‘93, Founder, Z Corporation
Amey Moot, XV SM ‘91, Director, Fletcher Spaght Ventures
Lita Nelsen, X SB ‘64, SM ‘66, XV SM ‘79, Director, MIT Technology Licensing Office
Mina Hsiang, VI-1 SB ‘03, MNG ‘05, MBA, Senior Associate, General Catalyst(Moderator)

 

REGISTER TODAY – $5 extra at the door

$12 Students || $15 AMITA Members & MIT10 || $18 MIT Alumni & Affiliates || $20 Guests

Tags:

Please reload